Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption.
Mucoadhesive drug delivery system is a part of controlled delivery system.
Since the early 1980,the concept of Mucoadhesion has gained considerable interest in pharmaceutical technology.
combine mucoadhesive with enzyme inhibitory & penetration enhancer properties & improve the patient complaince.
MDDS have been devloped for buccal ,nasal,rectal &vaginal routes for both systemic & local effects.
Hydrophilic high mol. wt. such as peptides that cannot be administered & poor absorption ,then MDDS is best choice.
Mucoadhesiveinner layers called mucosa inner epithelial cell lining is covered with viscoelasticfluid
Composed of water and mucin.
Thickness varies from 40 μm to 300 μm
General composition of mucus
Water…………………………………..95%
Glycoproteinsand lipids……………..0.5-5%
Mineral salts……………………………1%
Free proteins…………………………..0.5-1%
The mechanism responsible in the formation of mucoadhesive bond
Step 1 : Wetting and swelling of the polymer(contact stage)
Step 2 : Interpenetration between the polymer chains and the mucosal membrane
Step 3 : Formation of bonds between the entangled chains (both known as consolidation stage)
Electronic theory
Wetting theory
Adsorption theory
Diffusion theory
Fracture theory
Advantages over other controlled oral controlled release systems by virtue of prolongation of residence of drug in GIT.
Targeting & localization of the dosage form at a specific site
-Painless administration.
-Low enzymatic activity & avoid of first pass metabolism
If MDDS are adhere too tightlgy because it is undesirable to exert too much force to remove the formulation after use,otherwise the mucosa could be injured.
-Some patient suffers unpleasent feeling.
-Unfortunately ,the lack of standardized techniques often leads to unclear results.
-costly drug delivery system
Video Lecture is available at https://www.youtube.com/watch?v=DXu_CLgB4q0
Introduction, terminology/definitions and rationale, advantages, disadvantages, selection of drug candidates. Approaches to design-controlled release formulations based on diffusion, dissolution and ion exchange principles. Physicochemical and
biological properties of drugs relevant to controlled release formulations.
Powerpoint presentation on controlled drug delivery system. Its introduction, terminologies, rationale, advantages, disadvantages, selection of drug, approaches for designing controlled release formulations and physicochemical and biological properties of drug
Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption.
Mucoadhesive drug delivery system is a part of controlled delivery system.
Since the early 1980,the concept of Mucoadhesion has gained considerable interest in pharmaceutical technology.
combine mucoadhesive with enzyme inhibitory & penetration enhancer properties & improve the patient complaince.
MDDS have been devloped for buccal ,nasal,rectal &vaginal routes for both systemic & local effects.
Hydrophilic high mol. wt. such as peptides that cannot be administered & poor absorption ,then MDDS is best choice.
Mucoadhesiveinner layers called mucosa inner epithelial cell lining is covered with viscoelasticfluid
Composed of water and mucin.
Thickness varies from 40 μm to 300 μm
General composition of mucus
Water…………………………………..95%
Glycoproteinsand lipids……………..0.5-5%
Mineral salts……………………………1%
Free proteins…………………………..0.5-1%
The mechanism responsible in the formation of mucoadhesive bond
Step 1 : Wetting and swelling of the polymer(contact stage)
Step 2 : Interpenetration between the polymer chains and the mucosal membrane
Step 3 : Formation of bonds between the entangled chains (both known as consolidation stage)
Electronic theory
Wetting theory
Adsorption theory
Diffusion theory
Fracture theory
Advantages over other controlled oral controlled release systems by virtue of prolongation of residence of drug in GIT.
Targeting & localization of the dosage form at a specific site
-Painless administration.
-Low enzymatic activity & avoid of first pass metabolism
If MDDS are adhere too tightlgy because it is undesirable to exert too much force to remove the formulation after use,otherwise the mucosa could be injured.
-Some patient suffers unpleasent feeling.
-Unfortunately ,the lack of standardized techniques often leads to unclear results.
-costly drug delivery system
Video Lecture is available at https://www.youtube.com/watch?v=DXu_CLgB4q0
Introduction, terminology/definitions and rationale, advantages, disadvantages, selection of drug candidates. Approaches to design-controlled release formulations based on diffusion, dissolution and ion exchange principles. Physicochemical and
biological properties of drugs relevant to controlled release formulations.
Powerpoint presentation on controlled drug delivery system. Its introduction, terminologies, rationale, advantages, disadvantages, selection of drug, approaches for designing controlled release formulations and physicochemical and biological properties of drug
Approaches Of Gastro-Retentive Drug Delivery System or GRDDSAkshayPatane
Approaches Of Gastro-Retentive Drug Delivery System
Includes:
Floating and Non-Floating drug delivery system with their subtypes
Like Non-effervescent system, Effervescent system, Raft forming system,
High Density system, Expandable system, Muco-adhesive system,
Super porous hydrogel system and Magnetic Systems, etc.
Approaches Of Gastro-Retentive Drug Delivery System or GRDDSAkshayPatane
Approaches Of Gastro-Retentive Drug Delivery System
Includes:
Floating and Non-Floating drug delivery system with their subtypes
Like Non-effervescent system, Effervescent system, Raft forming system,
High Density system, Expandable system, Muco-adhesive system,
Super porous hydrogel system and Magnetic Systems, etc.
These systems are capable of controlling the rate of drug delivery, sustaining the duration of therapeutic efficacy, and/or targeting the delivery of drug to a tissue. Depending upon the technical sophistication, these rate-control drug delivery systems can be classified into three major categories: (i) pre-programmed drug delivery, (ii) activation-controlled drug delivery, and (iii) feedback-regulated drug delivery.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
3. GOAL OF CDDS
The goal of drug delivery system is to provide a therapeutic amount of drug to a
proper site in the body to achieve and maintain the desired drug concentration.
That is the drug delivery system should delivery drug at a rate dictated by the
needs of the body over a specified period of treatment
Delivery of drug by idealized objectives is divided into two drug delivery
system-
1. spatial placement
2. temporal drug delivery
SPATIAL PLACEMET -relates to targeting a drug to a specific organ or tissues
TEMPORAL DD -relates to controlling the rate of drug delivery to the target tissuesSGRRITS DEHRADUN 3
4. An appropriate the CDDS can be a major advance towards
solving these two problems That is the reason;that the
science and technology responsible for development of
control release pharmaceuticals in both Industrial and
academic laboratories.
NDDS/ADDS systems that could provide one or more of the
following benefits:
1. Controlled administration of a therapeutic dose at a desirable rate of delivery.
2. Maintenance of drug concentration within an optimal therapeutic range for
prolonged duration of treatment.
3. Maximization of efficacy-dose relationship.
4. Reduction of adverse side effects.
5. Minimization of the needs for frequent dose intake.
6. Enhancement of patient compliance
SGRRITS DEHRADUN 4
5. HISTORY
Post 1990 (is the modern era of controlled release technology)
From 1970-1990 (was involved in the control drug delivery and to understand the
barriers for various routes of administration)
From 1950-1970 (is the period of sustain drug release)
The history of control release technology can be divided roughly into 3 time period
–
SGRRITS DEHRADUN 5
6. DEFINITION
Sustained release, sustained action, controlled release, extended action,
timed release dosage forms are the terms used to identify drug delivery
systems that are designed to achieve a prolonged therapeutic effect by
continuously releasing medication over an extended period of time after the
administration of single dose.
The term “Controlled release” has become associated with those systems
from which therapeutic agents may be automatically delivered at predefined
rates over a long period of time.
But, there are some confusion in terminology between “Controlled release”
& “Sustained release”
SGRRITS DEHRADUN 6
7. COUNTINUOS-
Sustained Release :
• The term sustained release has been
constantly used to describe a
pharmaceutical dosage form formulated
to retard the release of a therapeutic
agent such that its appearance in the
systemic circulation is delayed &/or
prolonged & its plasma profile is sustained
in duration.
Controlled Release :
• It also implies a predictability &
reproducibility in the drug release
kinetics, which means that the release of
drug ingredient from a controlled
delivery system proceeds at a rate profile
that is not only predictable kinetically,
but also reproducible from one unit to
anotherSGRRITS DEHRADUN 7
8. An ideal controlled drug delivery system is the one which delivers the drug at a predetermined
rate, locally or systematically for a specified period of time.
SGRRITS DEHRADUN 8
10. ADVANTAGES :
1. Less fluctuation in drug blood levels.
2. Frequency reduction in dosing.
3. Improved patient convenience & compliance.
4. Increased safety margin of the high potency drugs.
5. Reduction in total health care cost.
6. Minimizes local side effects
7. Improve bioavailability of some drug
DISADVANTAGES :
1. Poor in vivo – in vitro correlation.
2. Possibility of dose dumping.
3. Retrieval of drug is difficult.
4. Higher cost of formulation.
Decreased systemic availability in comparison to immediate release conventional dosage
forms.
SGRRITS DEHRADUN 10
11. Based on the technical sophistication of the controlled-release
drug delivery systems (CRDDSs)can be classified as follows-
Rate preprogrammed drug delivery system
Activation-modulated drug delivery system
Feedback-regulated drug delivery system
Site targeting drug delivery system
SGRRITS DEHRADUN 11
12. 1. rate preprogrammed drug delivery system
Rate reprogrmmed drug delivery system-
Polymer membrane permeation-controlled drug
delivery system
Polymer matrix diffusion-controlled drug
delivery system
Microreservior partition-controlled drug delivery
systemSGRRITS DEHRADUN 12
13. 1.(a) Polymer membrane permeation-controlled drug
delivery system
In this type, drug is totally or partially encapsulated
within drug reservoir.
Its drug release surface is covered by a rate-controlling
polymeric membrane having a specific permeability.
Drug reservoir may exist in solid, suspension or solution
form.
The encapsulation of drug formulation inside the reservoir
compartment can be accomplished by molding,
capsulation, microencapsulation, or other techniques.
SGRRITS DEHRADUN 13
14. The rate of drug release is defined by,
Q = Km/r Ka/m DdDm x CR
t Km/r Dmhd + Ka/m Ddhm
Where,
Km/r & Ka/m = partition coefficient of the drug molecule from reservoir to rate controlling membran & from
membrane to aq. Layer respectively.
Dd & Dm = diffusion coefficient of rate controlling membrane & aqueous diffusion layer respectively.
hm & hd = thickness of rate controlling membrane & aqueous diffusion layer respectively.
CR = drug conc. In reservoir compartment
SGRRITS DEHRADUN 14
15. Important-
Release of drug molecules is
controlled by :
• Partition coefficient of the drug
molecule.
• Diffusivity of the drug molecule.
• The thickness of the rate
controlling membrane.
SGRRITS DEHRADUN 15
16. Ex. Progestasert IUD
The drug reservoir is a suspension of
progesterone & barium sulphate in silicone
medical fluid & is encapsulated in the vertical
limb of a T-shaped device walled by a non-
porous membrane of ethylene-vinyl acetate co-
polymer.
It is designed to deliver natural progesterone
continuously in uterine cavity at a daily dosage
rate of at least 65 μg/day to achieve
contraception for 1 year.
SGRRITS DEHRADUN 16
17. 1.(b) Polymer matrix diffusion-controlled drug
delivery system
In this type, drug reservoir is prepared by homogeneously dispersing drug particle in rate
controlling polymer matrix from either a lipophilic or a hydrophilic polymer.
The drug dispersion in the polymer matrix is accomplished by either,
1) blending therapeutic dose of drug with polymer or highly viscous base polymer, followed by
cross linking of polymer chains.
2) mixing drug solid with rubbery polymer at elevated temp.
The rate of the drug release from this system, Soluble drug
Q = (2ACRDp)1/2
Where,
Q/t1/2 - rate of release of drug
A – initial drug loading dose in the polymer matrix
CR – drug solubility in polymer
Dp – diffusivity of drug in polymer matrix
SGRRITS DEHRADUN 17
18. Release of drug molecule is controlled by
Loading dose
Polymer solubility of drug
Drug diffusivity in polymer matrix.
Ex. Nitro-Dur :
Nitro-Dur is a transdermal system contains nitroglycerin in
acrylic-based polymer adhesives with a resinous cross-linking
agent to provide a continuous source of active ingredient
SGRRITS DEHRADUN 18
19. It is designed for application on to intact skin for 24 hrs to provide a
continuous transdermal infusion of nitroglycerin at dosage rate of
0.5 mg/cm2/day for the treatment of angina pectoris.
SGRRITS DEHRADUN 19
20. 1.(c) Micro reservoir partition-controlled drug
delivery system
In this type, drug reservoir is fabricated by micro dispersion of an aqueous Suspension of drug
in biocompatible polymer to form homogeneous dispersion.
Depending upon the physicochemical properties of drugs & desired rate of drug release, the
device can be further coated with a layer of biocompatible polymer to modify the mechanism
& the rate of drug release.
The rate of drug release is defined by,
dQ = DpDdmKp / { nSp – DlSl(1-n)/h1. (1/k1+ 1/km) }
Where,
n = the ratio of drug conc. At the inner edge of the interfacial barrier over the drug solubility
in the polymer matrix.
m = a/b,
a – ratio of drug conc. In the bulk of elution solution over drug solubility in the same medium
b – ratio of drug conc. At the outer edge of the polymer coating membrane over drug
solubility in the same polymer
Dphd + DdhpmKp
SGRRITS DEHRADUN 20
21. Kl, Km & Kp = partition coefficient for the interfacial partitioning of the drug from the
liquid compartment to the polymer matrix, from the polymer matrix to the polymer-
coating membrane & from the polymer coating membrane to the elution solution
respectively.
Dl, Dp & Dd = diffusivities of the drug in the lipid layer surrounding the drug particle, the
polymer coating membrane enveloping the polymer matrix, & the hydrodynamic
diffusion layer surrounding the polymer coating membrane with the thickness hl, hp &
hd.
Sl & Sp = solubilities of the drug in the liquid compartments & in the polymer matrix,
respectively
Release of drug molecule is controlled by,
Partition coefficient
Diffusivity of drug
Solubility of drugSGRRITS DEHRADUN 21
22. Rate reprogrammed drug delivery may also be
classified -
Dissolution
controlled
Diffusion
controlled
Errosion
controlled
combination
SGRRITS DEHRADUN 22
23. DISSOLUTION CONTROLLED DRUG DELIVERY SYSTEM
These system are those where the rate limiting phenomenon responsible for
controlled drug release –
A)slow dissolution of drug
Slow dissolution rate of the reservoir membrane or matrix
In this approach the system contains a drug with high solubility and
dissolution rate eg.-metformin
So in this cases the rate controlling element is the slow dissolution of a
polymer by-encapsulation or coating with slow dissolving degradading
polymer
Eg of such polmers are-ethyl cellulose,poly meth ecrylates like
eudragit.glysryl mono sterate
SGRRITS DEHRADUN 23
24. DIFFUSION CONTROLLED DRUG DELIVERY SYSTEM
These system are those where the rate controlling step is not dissolution but diffusion
of the dissolved drug through the rate controlling elements .
The rate controlling elements in such a system is insoluble nonerrodible and non
degradable, is however porous in nature too aloe diffusion of the drug.
ERROSION CONTROLLED DRUG DELIVERY SYSTEM
It is define as physical disintegration of a polymer matrix as a result of degradation
and is characterized by material loss from the polymer n physical state. the
degradation is broad by hydrolysis ,ph, enzymes, or osmotic pressure.
Errosion may be of two types-
(1) surface erosion
(2) Bullk errosion
SGRRITS DEHRADUN 24
25. Activation modulated drug delivery
system
In this group of controlled release drug delivery system, these release of drug
molecules from the delivery system is activated by some physical, chemical, or
biochemical process and/or by energy supplied externally
SGRRITS DEHRADUN 25
26. Based on nature of the process or type of energy used they can be classified into-
Physical means
a. Osmotic
pressure-
activated DDS
b. Hydrodynamic
pressure-
activated DDS
c. Vapor
pressure-
activated DDS
d. Mechanically
activated DDS
e. Magnetically
activated DDS
SGRRITS DEHRADUN 26
27. 2. Chemical means
a. pH- activated DDS
b. Ion- activated DDS
c. Hydrolysis- activated DDS
3. Biochemical means
a. Enzyme- activated DDS
b. Biochemical- activated DDS
SGRRITS DEHRADUN 27
28. Osmotic controlled activated drug delivery system-
In this type, drug reservoir can be either solution or solid formulation contained within
semi permeable housing with controlled water permeability.
The drug is activated to release in solution form at a constant rate through a special
delivery orifice.
For the drug delivery system containing a solution formulation, the intrinsic rate of
drug release is defined by,
Q/t = Pw Am /Hm( πs – πe )
Q/t - rate of drug release
Pw - permiability of semipermiable housing
Am -effective S.A. of semipermiable housing
hm - thickness of semipermiable housing
( ps - pe) – differential osmotic pressure between the drug delivery system with osmotic pressure
ps & the environment with osmotic presure pe.
SGRRITS DEHRADUN 28
30. Osmotic pump
Osmotic pumps are more complex and provide better zero order drug
delivery they work on a principle of osmotic pressure .it contains 3
basic components-
1. Semipermeable membrane made up of cellulose acetate
(polymer)
2.Osmozen eg.mannitol,dextrose,PEO
3.Delivery orifice
Rate of drug delivery is directly proportional to osmotic pressure
Drug delivery oriphase should be within the range of 0.3 to 1 mm
SGRRITS DEHRADUN 30
31. ADV.OF OSMOTIC PUMPS
i. A true zero order release is possible
ii. Drug release is independent of PH
iii. Drug release rate is predictable and reproducible
Ex. Alzet Osmotic pump
SGRRITS DEHRADUN 31
32. b. Hydrodynamic pressure-activated Drug delivery system
Also called as push-pull osmotic pump.
This system is fabricated by enclosing a collapsible, impermeable container, which
contains liquid drug formulation to form a drug reservoir compartment inside rigid
shape-retaining housing.
SGRRITS DEHRADUN 32
33. These system follows a zero order release.
they however different from the osmotic pump in that a
hydrodynamic pressure generating to which aging to which is
water soluble HCL such as HPMC is used contains in 1
compartments and a drug solution in another compartments
which is a collapsible reservoir
Both these compartments contains water permeable housing
The HCL IN WATER GENERATES HYDRODYNAMIC
PRESSURE to push the drug out from the orifice
SGRRITS DEHRADUN 33
34. VAPOR PRESSURE-ACTIVATED DRUG DELIVERY SYSTEM
These system are dependent on vapor pressure as an energy source for drug
release.
The drug solution compartment is separated by a freely movable partitions and
thee whole system is enclosed in a rigid housing.
the pumping compartments contains a liquefied compressed gases that
vaporizes at body temperature,
That have loose the partitions to force the drugs out of the compartments
through a series of flow regulators.
Eg. development of infusion pump of heparin in anticoagulant therapy
Eg. Insulin pump in diabetes
SGRRITS DEHRADUN 34
35. The rate of drug release is defined by,
Q = d4 (Ps -Pe)
t 40.74 ml
Where-
Q/t - rate of drug release
d – inner diameter of cannula
l – length of cannula
(Ps -Pe)- the difference between the vapor pressure in the vapor
chamber & pressure at the implantation site.
m - viscosity of the drug solution.
SGRRITS DEHRADUN 35
36. Mechanically activated drug delivery system
In this type, drug reservoir is in
solution form retained in a
container equipped with
mechanically activated pumping
system.
A measured dose of the drug
formulation is reproducible
delivered in to a body cavity, for
ex. The nose through the spray
head upon manual activation of
the drug delivery pumping system
SGRRITS DEHRADUN 36
37. Ex. Metered-dose inhaler
the volume of solution delivered
is controllable, as small as 10-
100 ml & is independent of the
force & duration of the
activation applied as well as the
solution volume in the
container.
SGRRITS DEHRADUN 37
39. In this type, drug reservoir is a dispersion of peptide or protein powders in
polymer matrix from which macromolecular drug can be delivered only at a
relatively slow rate.
This low rate of delivery can be improved by incorporating electromagnetically
triggered vibration mechanism into polymeric device combined with a
hemispherical design.
Device is fabricated by positioning a tiny magnet ring in core of hemispherical
drug dispersing polymer matrix.
As the magnet is activated to vibrate by external electromagnetic field, drug
molecules are delivered at much higher rate.
SGRRITS DEHRADUN 39
40. Sonophoresis -activated drug delivery
system
Also called as Phonophoresis.
This type of system utilizes ultrasonic energy to activate or trigger the delivery of drug
from polymeric drug delivery device.
System can be fabricated from nondegradable polymer (ethylene vinyl acetate) or
bioerodiable polymer (poly[bis(p-carboxyphenoxy) alkane anhydride]
The potential application of sonophoresis to regulate the delivery of drugs was recently
reviewed.
SGRRITS DEHRADUN 40
41. Iontophoresis activated drug delivery
system
This type of system uses electrical current to activate & to modulate the diffusion of
charged drug across biological membrane.
Iontophoresis – facilitated skin permeation rate of charged molecule (i) consist of 3
components & is expressed by,
Ji
isp = Jp + Je +Jc
SGRRITS DEHRADUN 41
42. Where,
Jp – passive skin permeation flux.
= KsDs dC
hs
Ks = partition coefficient for interfacial partitioning from donor solution to
stratum corneum
Ds = diffusivity across the skin
dC = concentration gradient across the skin
hs
Je – electrical current driven permeation flux
SGRRITS DEHRADUN 42
43. HYDRATION ACTIVATED DRUG DELIVERY
SYSTEM
In this system, the drug reservoir is
homogeneously dispersed in a swell able polymer
matrix fabricated from a hydrophilic polymer
(ethylene glycol methacrylate).
The release of drug is controlled by the rate of
swelling of polymer matrix
SGRRITS DEHRADUN 43
44. PH- ACTIVATED DRUG DELIVERY SYSTEM
This type of chemically activated system permits
targeting the delivery of drug only in the region with
selected pH range.
It fabricated by coating the drug-containing core with a
pH – sensitive polymer combination.
For instances, a gastric fluid labile drug is protected by
encapsulating it inside a polymer membrane that resist
the degradative action of gastric pH.
SGRRITS DEHRADUN 44
46. An ionic or a charged drug can be delivered by this
method & this system are prepared by first complexing
an ionic drug with an ion-exchange resin containing a
suitable counter ion.
Ex. By forming a complex between a cationic drug with
a resin having a So3
- group or between an anionic drug
with a resin having a N(CH3)3 group.
The granules of drug-resin complex are first treated
with an impregnating agent & then coated with a
water-insoluble but water-permeable polymeric
membrane.
SGRRITS DEHRADUN 46
47. This membrane serves as a rate-controlling barrier to
modulate the influx of ions as well as the release of drug
from the system.
In an electrolyte medium, such as gastric fluid ions
diffuse into the system react with drug resin complex &
trigger the release of ionic drug.
Since the GI fluid regularly maintains a relatively
constant level of ions, theoretically the delivery of drug
from this ion activated oral drug delivery system can be
maintained at a relatively constant rate.
SGRRITS DEHRADUN 47
48. This type of system depends on the hydrolysis process to activate the release of drug.
Drug reservoir is either encapsulated in microcapsules or homogeneously dispersed in
microspheres or nano particles for injection.
It can also be fabricated as an implantable device.
All these systems prepared from bioerodible or biodegradable polymers (poly
anhydride, poly ortho esters ,poly lactide glycolate).
It is activated by hydrolysis-induced degradation of polymer chain & is controlled by
rate of polymer degradation.
Ex. Injectable microspheres for sub cutaneous delivery of luprolide (analogue of Gn-RH)
for treatment of cancers in men/treatment of prostate carcinoma.it release the drug
upto the period of 4 months.
Hydrolysis- activated drug delivery system
SGRRITS DEHRADUN 48
49. Enzyme - activated drug delivery
system
This type of biochemical system depends on the
enzymatic process to activate the release of drug.
Drug reservoir is either physically entrapped in
microspheres or chemically bound to polymer
chains from biopolymers (albumins or
polypeptides).
The release of drug is activated by enzymatic
hydrolysis of biopolymers (albumins or
polypeptides) by specific enzyme in target tissue.
SGRRITS DEHRADUN 49
50. Feedback regulated drug delivery system
In this group the release of drug molecules from the delivery system is activated
by a triggering agent.
Rate of drug release is controlled by concentration of triggering agent
SGRRITS DEHRADUN 50
51. They are further classified as-
Bio erossion-regulated
drug delivery system
Bioresponsive drug
delivery system
Self-regulating drug
delivery system
SGRRITS DEHRADUN 51
52. A. Bioerosion-regulated drug delivery system
The system consisted of
drug dispersed
bioerrodible matrix
fabricated from poly
(vinyl methyl ether)
ester which is coated
with layer of
immobilized urease.
SGRRITS DEHRADUN 52
53. In this drug delivery
systems the release
of drug molecules
from the delivery
system is activated
by a triggering
agent such as a
biochemical agent
in the body.
eg. PH change or
enzymes is
regulated by it’s
concentration ,and
rate of drug
delivery is
controlled by the
concentration of
triggering agent.
This system consists
of drug disperse in
a bioerrodible
matrix and coated
with a layer of
immobilized urease
SGRRITS DEHRADUN 53
54. Cont.……
In a solution at neutral PH the
polymer errodes slowly but in
the presence of urea ,the
urease at the surface gets
activated and metabolizes urea
to give ammonia which increase
the PH and possesses rapid
degradation of polymer matrix
resulting in drug release.
SGRRITS DEHRADUN 54
55. B. Bio responsive drug delivery system
Drug reservoir is contained in device enclosed by
bio responsive polymeric membrane(poly vinyl
methyl ether ) whose drug permeability is
controlled by concentration of biochemical agent.
Ex. – glucose-triggered insulin drug delivery
system.
SGRRITS DEHRADUN 55
57. SGRRITS DEHRADUN 57
In alkaline solution, the –NR2 are neutral &
the membrane is un swollen & impermeable
to insulin.
In this system, the insulin reservoir is
encapsulated within hydro gel membrane
having –NR2 group.
Glucose penetrates into the membrane, it
oxidizes enzymatically by the glucose oxidase
entrapped in the membrane to form gluconic
acid.
The –NR2 group is protonated to form –NR2H+
& the hydro gel membrane then becomes
swollen & permeable to insulin molecules.
58. Self-regulating drug delivery system
This type of system depends on a reversible &
competitive binding mechanism to activate and to
regulate the release of drug.
Drug reservoir is drug complex encapsulated within a
semi permeable polymeric membrane.
The release of drug from the delivery system is
activated by the membrane permeation of
biochemical agent from the tissue in which the
system is located.
SGRRITS DEHRADUN 58
59. Ex. In the complex of glycosylated insulin concanavalin A, which is encapsulated inside
a polymer membrane.
Glucose penetrates into the system & it activates the release of glycosylated
insulin from the complex for controlled delivery out of system
SGRRITS DEHRADUN 59
61. REFERENCE-
Novel drug delivery system
Bio pharmaceutics & pharmacokinetics- Brahmankar.
Fundamentals of controlled release drug delivery-
Robinson
The science and practice of pharmacy(20th edition)-
Remington
Web – www.google.com
SGRRITS DEHRADUN 61